Filing · LD-1 registration
Registration
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jun 15, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Missouri
Lobbyists on this filing
2
-
JOHN MARTIN New on this filingPreviously held: Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.
-
ANN JABLON New on this filingPreviously held: Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal.
Lobbying activity
1
Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.
Foreign interests disclosed
1
-
CAPVEST PARTNERS LLPUnited Kingdom · London · owns 100% of the client · contributed $0